Target intelligence / Profile preview

Host cell receptors for attenuated measles, mumps, and rubella viruses (MMR receptors)

Target
MMR receptors
Molecular classification
Receptor, Glycoprotein, Cell adhesion molecule
01

Overview

The host cell receptors for attenuated measles, mumps, and rubella viruses are a collection of surface molecules that mediate the entry of vaccine-strain viruses into host cells. For the attenuated measles virus (Edmonston strain), the primary receptor is Membrane cofactor protein (CD46), which is a regulator of the complement system (Dorig et al., 1993). This is distinct from wild-type measles virus, which uses Signaling lymphocytic activation molecule family member 1 (SLAMF1) and Nectin-4. Mumps virus utilizes sialic acid residues, particularly alpha-2,3-linked sialic acids, as receptors for its hemagglutinin-neuraminidase protein (Kubota et al., 2016). Rubella virus has been identified to use Myelin oligodendrocyte glycoprotein (MOG) as a key entry receptor, which is significant given the virus's potential for neurological involvement (Cong et al., 2011). These receptors are critical for the efficacy of the MMR vaccine, as they allow the attenuated viruses to infect cells and stimulate a robust, long-lasting immune response. Understanding these interactions is essential for evaluating vaccine safety, especially in patients with underlying immunological or neurological conditions.

Other names
Membrane cofactor protein (CD46)Sialic acidMyelin oligodendrocyte glycoprotein (MOG)CD150 (SLAMF1)Nectin-4Cell adhesion molecule 1 (CADM1)
02

Mechanism of action

The attenuated viruses in the MMR vaccine bind to these specific host receptors (CD46 for measles, sialic acid for mumps, and MOG for rubella) to trigger membrane fusion and viral entry, leading to a controlled infection that stimulates long-term adaptive immunity.

03

Biological functions

Viral entryComplement regulationCell-cell adhesionImmune response
04

Disease associations

InfectionMeaslesMumpsRubella
05

Safety considerations

Vaccine-associated adverse eventsImmunocompromised state contraindicationsViral persistenceMOG-antibody associated disease (MOGAD) mimicry
06

Interacting drugs

Measles, Mumps, and Rubella Virus Vaccine Live

1 more in the full profile.

07

Biomarkers

CD46 expression levelsSialic acid densityMyelin oligodendrocyte glycoprotein (MOG) expressionNeutralizing antibody titers

Beyond the preview

Go deeper on Host cell receptors for attenuated measles, mumps, and rubella viruses (MMR receptors).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host cell receptors for attenuated measles, mumps, and rubella viruses (MMR receptors).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call